To the largest TB-drug pipeline in history.
Since then, TB Alliance and its diverse and extensive network of partners have embarked on a transformation of the TB drug development landscape. Today, TB Alliance has introduced innovations in TB treatment and manages the largest research pipeline of new TB drugs in history.See our portfolio
We are working toward our goal to end TB.
TB Alliance is not just developing new drugs but changing the way TB drugs are developed. Our mission is not complete until new drugs are in the hands of those who need them.
It’s our mission to develop better treatments for tuberculosis that are accessible to the millions who are impacted by this deadly infectious disease. We have an opportunity to advance the pipeline of therapeutics that have the potential to significantly improve and shorten the TB treatment experience for patients.”— Dr. Maria Beumont, Vice President and Chief Medical Officer
Get to know our team members
TB is one of the world’s oldest and deadliest diseases, but the global response to the TB pandemic is falling far short. We’re a team of experts in TB biology, chemistry, clinical trials, and product introduction who work with partners around the world to achieve our vision of a future in which no one dies of TB.
Working @ TB Alliance
We’ve all come to know the power of infectious diseases, but we also know the power of science. Hear more from our team at TB Alliance about how our work impacts the advancement of new TB drug research, development, and delivery.